1. Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol. (January 2022) Authors: Stutterheim, J.; de Lorenzo, P.; van der Sluis, I.M.; Alten, J.; Ancliffe, P.; Attarbaschi, A.; Aversa, L.; Boer, J.M.; Biondi, A.; Brethon, B.; Diaz, P.; Cazzaniga, G.; Escherich, G.; Ferster, A.; Kotecha, R.S.; Lausen, B.; Leung, Alex WK.; Locatelli, F.; Silverman, L.; Stary, J. Journal: European journal of cancer Issue: Volume 160(2022) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗